- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: firstname.lastname@example.org
--Project Demonstrates Commitment of two World-Class Organizations to the Advancement of Research and Treatment in These Childhood Cancers--
January 10th, 2013, Philadelphia and Shenzhen, China – The Children’s Hospital of Philadelphia (CHOP) and BGI-Shenzhen today announced a formal agreement to collaborate on research into next-generation sequencing and analysis of pediatric brain tumors, in support of the Childhood Brain Tumor Tissue Consortium (CBTTC). The research initiative will draw on the resources of the state-of-the-art Joint Genome Center BGI@CHOP. That center provides next-generation sequencing (NGS) under CAP/CLIA guidelines, which represent the gold standard of quality in clinical laboratory testing.
The CBTTC is a collaborative pediatric research group that brings together four institutions: The Children’s Hospital of Philadelphia (which houses the Operations Center) and the Children’s Hospital of Pittsburgh, Seattle Children’s Hospital and Lurie Children’s Hospital of Chicago. The consortium is dedicated to the collection, annotation, and molecular analyses of children’s brain tumors. Next- generation sequencing of pediatric brain tumors offers a deep and comprehensive view into the genetic underpinnings of these often-devastating solid tumors. In collaboration with BGI’s genomics platforms, the new project will support the development of new and more effective forms of therapy targeted to each patient’s specific subtype of brain tumor.
Tom Curran, Ph.D., FRS, Deputy Scientific Director of the CHOP Research Institute, commented, “These important efforts are made possible through the further extension of CHOP’s productive collaboration with BGI, a world-class institution in the global genome sequencing arena that is using its scientific expertise and technological know-how to improve medical research.”
“BGI is pleased to have deepened its relationship with The Children’s Hospital of Philadelphia, a global leader in pediatric care and research,” said Dr. Jun Wang, Executive Director of BGI-Shenzhen. “We look forward to a productive partnership that will accelerate advances in the research and treatment of pediatric brain tumors.”
Supported by CHOP’s and BGI’s excellent infrastructure and extensive experience in NGS services, the BGI@CHOP Joint Genome Center was established in November 2011 under a partnership between both institutions to focus on discovery of genes underlying rare and common pediatric diseases.
About The Children’s Hospital of Philadelphia
The Children’s Hospital of Philadelphia was founded in 1855 as the first pediatric hospital in the United States. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children’s Hospital has fostered many discoveries that have benefited children worldwide and its pediatric research program is among the largest in the U.S. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. Support for the establishment of the CBTTC has been provided in part by the Children’s Brain Tumor Foundation. For more information, visit http://www.chop.edu.
The Children’s Hospital of Philadelphia
Joyce Peng, Ph.D.
BGI Americas Corporation